NCT02026583 A Single Arm, Phase II Study of Simvastatin Plus XELOX and Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer Patients Status COMPLETED Phase PHASE2
NCT02024412 Monosialotetrahexosylganglioside Sodium Injection for Prevention Neurotoxicity of mFOLFOX 6 in mCRC Status UNKNOWN Phase PHASE3
NCT02020291 Phase I Study to Evaluate Safety, Tolerability, Anti-Tumour Activity and PK Profiles of Foxy-5 in Metastatic Breast, Colon or Prostate Cancer Status COMPLETED Phase PHASE1
NCT02015754 Irinotecan -Eluting LC Bead-M1 (DEBIRI-M1) for Patients With Liver Metastases From Colorectal Cancer Status COMPLETED Phase PHASE2
NCT02012231 Phase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers. Status TERMINATED Phase PHASE1
NCT02008383 Cabozantinib and Panitumumab to Treat KRAS Wild-Type Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT02005614 A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection Status TERMINATED Phase NA
NCT02002299 Does Surface Tell us About the Invasive Front in Colorectal Cancer Status UNKNOWN Phase N/A
NCT02000180 Colonoscopic Skill Acquisition and Transfer Via Simulated Curriculum of Progressive Training Status COMPLETED Phase NA
NCT01997684 Colonic Stenting With Elective Surgery Versus Emergency Surgery in the Management of Acute Malignant Colonic Obstruction Status UNKNOWN Phase NA
NCT01991522 A Randomized Control Trial of a Simulation-based Curriculum to Enhance Skills in Colonoscopy Status COMPLETED Phase NA
NCT01985763 Genistein in Treatment of Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01983371 Diagnostic Accuracy of Ferumoxytol-Enhanced MRI for Detecting Lymph Node Metastases in Colorectal Cancer Status WITHDRAWN Phase NA
NCT01978249 A Randomized, Prospective, Multicenter Study for the Role of Primary Tumor Resection in Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastasis Status TERMINATED Phase NA
NCT01975831 A Phase 1 Study to Evaluate MEDI4736 in Combination With Tremelimumab Status COMPLETED Phase PHASE1